You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This package offers the combined benefits of both the print and the web-based presentation, for the very reasonable additional price of approximately $60 over the cost of the book alone. G&G is the acknowledged authority on the properties, mechanisms, and uses of the major drug classes. One of the most successful books in the history of medical publishing (more than 1,000,000 copies sold!), it is renowned worldwide for detailed but clinically applicable coverage. The G&G Digital Edition includes LOT access to G&G On Line, with its advanced search engine, PDA “cut and paste” capability, hyperlinked references, and other new features developed specifically for G&G On Line.
First multi-year cumulation covers six years: 1965-70.
This book covers a wide range of novel biochemical targets that appear to be the best leads in terms of designing novel targets for anticancer drug design. New Molecular Targets for Cancer Chemotherapy is a unique, multi-disciplinary effort, with internationally respected authors from the fields of growth factor-receptor interaction, phosphoinositide and phospholipase signal transduction, and DNA-drug binding interactions. The science is placed in clinical context and illustrations explain how clinicians can incorporate a mechanistic, pharmacodynamic approach into early clinical trial design.
None
There has always been some tension between proponents of hypothesis-driven and discovery-driven research in the broad field of life sciences. Academic research has been primarily focused on hypothesis-driven research. However, the success of the human genome project, a discovery-driven research approach, has opened the door to adding other types of discovery-driven research to a continuum of research approaches. In contrast, drug discovery research in the pharmaceutical industry has embraced discovery-driven research for many years. A good example has been the discovery of active compounds from large chemical libraries, through screening campaigns. The success of the human genome project has...
Advances in molecular biology over the last several decades are being steadily applied to our understanding of the molecular biology of cancer, and these advances in knowledge are being translated into the clinical practice of oncology. This volume explores some of the most exciting recent advances in basic research on the molecular biology of cancer and how this knowledge is leading to advances in the diagnosis, treatment, and prevention of cancer. - This series provides a forum for discussion of new discoveries, approaches, and ideas - Contributions from leading scholars and industry experts - Reference guide for researchers involved in molecular biology and related fields